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Abstract
Aims: Morphine signaling via the l-opioid receptor (MOR) is coupled to redox-dependent zinc release from
endogenous stores. Thus, MOR activation stimulates the complex formed by RGSZ2 (a regulator of G protein
signaling) and neural nitric oxide synthase (nNOS) to produce NO, and to recruit PKCc and Raf-1 in a zinc-
dependent manner. Accordingly, we investigated whether redox regulation of zinc metabolism was unique to
the MOR, or if it is a signaling mechanism shared by G-protein coupled receptors (GPCRs). Results: A physical
interaction with the RGSZ2–nNOS complex was detected for the following GPCRs: neuropeptides, MOR and d-
opioid (DOR); biogenic amines, 5HT1A, 5HT2A, a2A, D1 and D2; acetylcholine, muscarinic M2 and M4; ex-
citatory amino acid glutamate, mGlu2 and mGlu5; and derivatives of arachidonic acid (anandamide), CB1.
Agonist activation of these receptors induced the release of zinc ions from the RGSZ2 zinc finger via a nNOS/
NO-dependent mechanism, recruiting PKCc and Raf-1 to the C terminus or the third internal loop of the GPCR.
Innovation: A series of GPCRs share an unexpected mechanistic feature, the nNOS/NO-dependent regulation of
zinc ion signaling via a redox mechanism. The RGSZ2 protein emerges as a potential redox zinc switch that
converts NO signals into zinc signals, thereby able to modulate the function of redox sensor proteins like PKCc
or Raf-1. Conclusion: Redox mechanisms are crucial for the successful propagation of GPCR signals in neurons.
Thus, dysfunctions of GPCR-regulated NO/zinc signaling may contribute to neurodegenerative and mood
disorders such as Alzheimer’s disease and depression.
Antioxid. Redox Signal. 00, 000—000.
Introduction
Emerging evidence suggests an important role for zincmetabolism in cell signaling. This trace metal element is
particularly abundant in the mammalian brain, with con-
centrations in the lM range; yet resting free cytosolic zinc ions
only reach concentrations in the pM to low nM range. With
the appropriate regulation, transient increases in intracellular
zinc ion concentrations can be produced that are immediately
buffered to the aforementioned resting levels (4). This tight
regulation of endogenous levels implicates zinc in redox-
mediated cell signaling.
In neural tissue, nitric oxide synthase (nNOS) is pri-
marily responsible for the production of nitric oxide (NO),
which regulates a broad range of physiological functions.
NO exerts most of action by reacting with cysteine Zn/S
sites in zinc finger proteins, promoting the release of zinc
and the S-nitrosylation of these thiol groups (32, 49). The
nitrosylation of cysteines is readily reversible, typically via
the S-nitrosoglutathione reductase or thioredoxin systems
(31, 49).
While nNOS activation is typically linked to the NMDA
glutamate receptor, the G protein-coupled l-opioid receptor
(MOR) also stimulates NO production by regulating nNOS
(47). The MOR is associated with nNOS through a series of
regulatory proteins and, for example, the RGSZ2 protein
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binds the PDZ binding motifs located in the N-terminal region
of nNOS, thereby inhibiting NO production (14). RGSZ2
binding to the histidine triad nucleotide-binding protein 1
(HINT1) connects it to the MOR C-terminus (1, 18, 43). Indeed,
the MOR agonist, morphine, activates GaGTP subunits, some
of which bind to the RGSZ2-nNOS complex and provoke
transient production of NO (43, 47). One of the main physi-
ological consequences of MOR-mediated NO production is
the release of zinc ions from endogenous stores. Subse-
quently, these ions can bind to cysteine-rich regions in PKCc
and Raf-1, promoting their simultaneous recruitment to the
HINT1 protein at the MOR (45, 46). The role of zinc signals
as intracellular messengers is dependent on their temporal
and spatial compartmentalization. Notably, rather than
protecting SH groups from oxidation, the strong binding of
zinc to sulfur in cysteine thiol groups increases the vulner-
ability of thiolates to oxidation (33). This results in redox-
active zinc/cysteine coordination environments that
respond to mild physiological oxidation by releasing zinc
ions, such as that produced by NO. By contrast, zinc-free
cysteines remain unaffected and ready to capture free zinc
ions (20). When coupled with the reversibility of zinc
binding upon reduction of the oxidized sulfur, this property
makes cysteine-coordinated zinc fingers efficient redox
sensors (33). Binding of HINT1 and RGSZ2 to cytosolic re-
gions of GPCRs is not restricted to the MOR; we have also
detected this interaction in the cannabinoid CB1 receptor, as
well as to a lesser extent in the d-opioid receptor (DOR) (10).
As activation of the PLC/PKC and ERK1/2 pathways is
shared by many GPCRs, we investigated whether regula-
tion of nNOS and Redox release of endogenous zinc is a
general feature of GPCR signaling in nervous tissue. Given
the exquisite compartmentalization of nNOS regulation to
the MOR’s C terminus, we explored the possibility that the
cysteine-rich domain (CRD) of the RGSZ2 N terminus could
act as source of endogenous zinc ions released by GPCR-
activated nNOS.
Results
Activation of different GPCRs promotes the release
of endogenous zinc ions via a mechanism
involving nNOS/NO
We sought to investigate whether the redox-induced mo-
bilization of endogenous zinc was a signaling property shared
by a range of neural GPCRs. First, we analyzed the capacity to
mobilize zinc of agonists that act on GPCRs known to contain
HINT1 at their corresponding C termini, such as MOR, CB1R,
and DOR (10). As reported previously (45), incubation of
mouse brain slices with morphine increased Newport Green
fluorescence (a measure of the zinc ions that are being released
from endogenous stores), a MOR-mediated effect that was
attenuated by the opioid antagonist naloxone. Likewise, the
zinc-mobilizing effect of deltorphin II, a DOR agonist, was
attenuated by its selective antagonist, naltrindole and simi-
larly, the effect of the CB1R agonist, WIN 55-212-2, dimin-
ished following LY320135 administration, a specific
antagonist of this receptor (Fig. 1). Taken together, these
findings demonstrate that metabotropic GPCRs for endoge-
nous opioid peptides (MOR and DOR) and for the arachi-
donic acid derivative anandamide (CB1R) are all capable of
provoking the release of endogenous zinc ions.
We found that several neural receptors for biogenic amines
(5HT1A and 5HT2A serotonin receptors, the a2A nora-
drenegic receptor, and D1 and D2 dopamine receptors) me-
diated the mobilization of zinc ions in response to agonist
stimulation (Fig. 2). Dopamine receptor-mediated zinc mo-
bilization was promoted by quinpirole, a specific D2 agonist,
and by apomorphine, which acts on both D1R and D2R types.
These effects were attenuated by GPCR antagonism, and they
were also prevented by NOS/NO inhibition.
The RGSZ2 protein is a redox sensor that releases
zinc ions in response to NO
The RGS17 protein, also known as RGSZ2, belongs to the
Rz subfamily of RGS proteins (21, 30). Immediately upstream
of the RGS domain, RGSZ2 contains a series of PDZ binding
motifs that bind to the PDZ domain in nNOS (residues 61–64
MESI, 75–78 ADEV, and 76–79 DEVL). In the MOR, the
RGSZ2–nNOS interaction serves to regulate NO production
and the release of zinc from intracellular stores in response
to morphine binding (14). Importantly for NO signaling,
the amino terminus of RGSZ2 features a cysteine-rich do-
main (CRD: 28 to 40) that contains 9 cysteine residues out of
a total of 13.
To determine whether RGSZ2 CRD could bind zinc ions
and release them in response to NO donors, the N terminal
region on RGSZ2 (1–80) containing the CRD was exposed to
the NO generators SNAP and NOR-3 (100 lM), which re-
leased about two molar equivalents of zinc (Fig. 3A). A similar
level of zinc release was observed in response to oxidation
induced by 2.5 mM hydrogen peroxide, a concentration that
induces maximal release of zinc ions from PKC zinc fingers
(24, 50), or by a combination of SNAP and H2O2. Phorbol-12-
myristate-13-acetate (PMA) produced no detectable release
of zinc ions from the RGSZ2 CRD (Fig. 3B). Computati-
onal analysis revealed a linear arrangement of double zinc
motifs in the RGSZ2 zinc finger [metal binding sites: http://
www.geneinfinity.org; DCPB: http://120.107.8.16/dbcp/
accessed on Jul 2, 2012; (34)]. The zinc-binding ligands in the
RGSZ2 CRD are implicated in the tetrahedral coordination of
each zinc atom with four cysteine ligands (S4), a structure
termed the zinc ribbon (32). While the other members of the
RGS-Rz subfamily can theoretically bind zinc via their CRDs,
RGS19(GAIP) and RGS20(Z1), they could only accommodate
one atom in a cysteine tetrahedral coordination (Fig. 3C).
Impairment of RGSZ2 protein expression markedly
attenuates GPCR-induced zinc release from
endogenous stores
The RGSZ2 protein appears to play an essential role in
cellular homeostasis and, indeed, targeted deletion of its gene
is lethal. Thus, the relevance of this protein was determined by
reducing its expression in adult mice (11, 14). In brain slices
from mice with impaired RGSZ2 expression, GPCR agonists
induced the release of nondetectable to moderate levels of
endogenous zinc (Fig. 4).
GPCRs associate with RGSZ2 and HINT1 proteins
in brain synaptosomes
The association of the RGSZ2/nNOS signaling complex
with the HINT1 protein at the MOR C terminus appears
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necessary for morphine to regulate the production of NO and
the subsequent release of zinc from endogenous zinc finger
proteins (1, 14, 46). Therefore, we explored whether the
GPCRs of interest were also associated with these proteins in
brain synaptosomes. Antibodies recognizing external epi-
topes on the GPCRs were used to immunoprecipitate the
corresponding receptor (Fig. 5A), thereby avoiding the
blockage of their cytosolic sequences that may occur due to
interaction with third partner proteins, such as G proteins,
RGS proteins, or others. The ex vivo assays revealed that all
GPCRs studied co-precipitated RGSZ2, nNOS, and HINT1
proteins (Fig. 5B). This finding indicates that, in addition to
regulating G proteins, GPCRs may also promote the activa-
tion of nNOS/NO pathways.
FIG. 1. Signaling via the
MOR, DOR, and CB1R is
linked to zinc release via
nNOS/NO activation. Coronal
mouse brain slices were pre-
loaded with 50lM cell-perme-
able Newport Green diacetate
for 1 h and after its removal, the
preparations were assayed. The
evolution of spontaneous re-
lease of endogenous zinc was
determined in Control (un-
treated) sections. For each re-
ceptor, consecutive sections
were used to analyze the effect
of the agonist alone or in com-
bination with the antagonist or
L-NNA. Fluorescent images
were taken at various intervals
using a 10·0.4 HC PL APO
objective (excitation, 488; emis-
sion, 498–520) and the regions
studied for each GPCR are in-
dicated. The data at 30 and
60 min post-treatment are
shown for baseline vehicle
(Control), agonist (3lM) trea-
ted (A), agonist + antagonist
(10lM) treated (Antagonist +
A), and agonist + L-NNA
(10lM) treated slices (L-NNA
+ A). The following agonists
and their antagonists were
used: MOR, morphine (Merk)
and naloxone (Tocris 0599);
DOR, deltorphin II (Tocris
1180) and naltrindole (Tocris
0740); CB1R, Win55,212-2 (To-
cris 1038), and LY320135 (To-
cris 2387). Images were color
indexed, and presented in gray
and pseudocolor (no treat-
ment), or pseudocolor only (for
receptor studies). The numbers
on the images indicate the lu-
minosity corresponding to the
red channel (indicative of fluo-
rescence variation with respect
to the control). Scale bar=500
lm. The assay was typically
repeated at least twice on brain
coronal slices from different
mice, with comparable results.
Representative images are
shown. (To see this illustration
in color the reader is referred to
the web version of this article at
www.liebertpub.com/ars).
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FIG. 2. Activation of 5HT1A
and 5HT2A serotonin recep-
tors, a2A adrenoceptors, and
D1 and D2 dopamine recep-
tors promotes the release of
zinc ions via nNOS/NO. All
details as in Figure 1. The fol-
lowing GPCR agonists and an-
tagonists were used: 5HT1AR,
8H-DPAT (Tocris 1080) and
NAN-190 (Tocris 0553);
5HT2AR, DOI (Tocris 2643) and
AF 4PP (Tocris 0523); a2AR,
clonidine (Tocris 0690) and yo-
himbine (Tocris 1127); D2R,
quinpirole (Tocris 1061) and
haloperidol (Tocris 0935); D1R/
D2R, apomorphine (Tocris
2073). (To see this illustration in
color the reader is referred to the
web version of this article at
www.liebertpub.com/ars).
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RGSZ2 physically interacts with the cytosolic C
terminus or the third internal loop of GPCRs
GPCRs exhibit notable differences in the length of the C
terminus and third internal loop, regions that are essential for
their interaction with signaling proteins and the regulation of
their activities. When we studied the characteristics of these
sequences for the GPCRs of interest (Fig. 5B), a short C ter-
minal sequence was usually balanced by a long third internal
loop and vice versa. Therefore, apart from the regulation of G
proteins depending on the class of GPCR, cytosolic interac-
tions probably occur via either the C terminus or the third
internal loop.
The MOR C terminus requires the HINT1 protein to recruit
RGSZ2 (43), although RGSZ2 can also interact directly with
other GPCRs. The formation of RGSZ2–GPCR complexes
in vivo was supported by the results the bimolecular fluores-
cence complementation (BiFC) analysis (Fig. 6). Chinese
hamster ovary (CHO) cells were transfected with a mix of
RGSZ2 coupled to VC155 (1:1) and the GPCR of interest
coupled to the C terminus of VN173. The physical association
of RGSZ2 with the GPCR allows the VC155 and VN173
fragments to form a stable fluorescent complex, which could
be detected in several cells.
The participation of amino acid sequences of the C terminal
or the third internal loop in the GPCR–RGSZ2 interaction was
determined by surface plasmon resonance analysis. The C
terminal sequences of CB1 and 5HT2A, and the third internal
loop sequences of a2A, M2, M4, D2, and 5HT1A, were cova-
lently coupled to a CM5 sensor chip. Real-time interactions
were studied by passing a solution containing the RGSZ2
protein over the sensor surface, and RGSZ2 was seen to in-
teract directly with the C terminus or third cytosolic loop of
these receptors. These findings demonstrate that RGSZ2 can
be recruited to the GPCR environment either directly or
through its binding to the HINT1 protein.
Zinc supports the translocation of signaling proteins
to the GPCR environment in vitro and ex vivo
The interaction through which the RGSZ2 protein binds to
the HINT1 protein was not affected by adding zinc to the
medium. However, as purified recombinant zinc-binding
proteins contain zinc, the RGSZ2-HINT1 interaction was also
evaluated after experimental removal of this metal ion, which
did not affect this association (Fig. 7A). Similarly, the binding
observed between recombinant HINT1 and PKCc was not
affected by exogenously added zinc, although HINT1-PKCc
binding was clearly impaired after removing protein-bound
zinc. In these circumstances, the addition of free zinc ions to
the incubation media promoted a stronger interaction than
that observed prior to zinc removal (Fig. 7A).
Besides the PKCc CRD, that of Raf-1 also exhibits a zinc-
dependent association with the MOR (45). Using membranes
derived from mouse brain tissue, we determined the capacity
of added zinc ions to promote the association of these sig-
naling proteins with various GPCRs. The membranes were
exposed for 4 h to increasing concentrations of zinc at 4C
before the GPCR was immunoprecipitated, and in the pres-
ence of low nM zinc, 5HT1A, 5HT2A, CB1, and D2 associated
with Raf-1 and PKCc (Fig. 7B). Moreover, the NO donor
SNAP enhanced the association of GPCRs with PKCc in
these membrane preparations, although this interaction was
FIG. 3. The CRD of RGSZ2 protein is a zinc finger that
coordinates the binding of two zinc atoms. (A) The cluster
of cysteines in the N terminus region of RGSZ2 binds zinc
and is redox sensitive. Time-dependent release of Zn2 + from
RGSZ2 CRD was induced by maximal doses (100lM) of the
NO donors SNAP or NOR-3. The N terminal region of
RGSZ2 containing the CRD (20lM) was incubated with the
NO donors (100lM) at RT. Zinc release was monitored at
different intervals through its complexing with the zinc
chelator Zincon and absorbance (600 nm) was recorded at RT
on a BioChrom Ultrospec 2100 spectrophotometer (Cam-
bridge, UK). The data represent the mean – SEM of three
independent assays. (B) Release of Zn2 + from the RGSZ2
CRD induced by phorbol ester and peroxide. The RGSZ2 N
terminal sequence containing the CRD was incubated with
PMA (1 mM), hydrogen peroxide (2.5 mM), or SNAP
(100 lM). The bar histogram represents the mean– SEM of
three independent experiments. (C) The CRD is present in N
terminal sequences of the members of the RGS-Rz subfamily.
Computational analysis of these proteins (34) revealed that
the RGSZ2 zinc finger contains a linear arrangement of two
zinc motifs capable of binding two zinc atoms (Metal detector:
http://metaldetector.dsi.unifi.it/; DCPB: http://120.107.8.16/
dbcp/). The zinc-binding ligands in RGSZ2 CRD form a tet-
rahedral coordination for each zinc atom with four cysteine
ligands (S4), a structure known as a zinc ribbon (32).
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attenuated in the presence of the heavy-metal chelator, TPEN
(Fig. 8A). Phorbol esters and calcium are cofactors that con-
tribute to the activation of the conventional PKC isoforms.
The binding of DAG or phorbol esters (PMA) to the regulatory
domain of PKC causes the release of some of the associated
zinc ions (23, 24, 50), as well as promoting the release of PKC
from the GPCR. In our membrane assays, we also observed
that PMA diminished the association of PKCc with all the
GPCRs evaluated (Fig. 8B). In vitro, PMA disrupted the as-
sociation between recombinant HINT1 and PKCc proteins
mediated by zinc, and promoted the activation of the PKCc
released (Fig. 8C).
Discussion
In the present study, the regulation of NO production and
the subsequent release of zinc ions from intracellular stores by
neuronal GPCRs have been described. In the light of this data,
the RGSZ2 protein emerges as a potential redox transducer
that can be regulated by a variety of GPCRs. Zinc ions re-
leased from the RGSZ2 zinc finger domain by the action of NO
can facilitate the coupling of redox sensor proteins such as
PKCc or Raf-1 to the C terminal or third internal loop of these
metabotropic receptors. Thus, redox signaling represents a
process used commonly by the most abundant subfamily of
cell surface receptors, mobilizing zinc ions from intracellular
stores to successfully integrate their signals into adaptive
neuronal processes.
The GPCRs analyzed all associate with the RGSZ2 zinc
finger protein and with the HINT1 protein, which recruits a
series of regulatory proteins to the GPCR’s environment in a
NO and zinc-dependent manner, including PKCc and Raf-1.
The RGSZ2 and HINT1 proteins are widely distributed
throughout the CNS (11, 28, 30), and they co-localize with
GPCRs in the cell membrane where they contribute to the
propagation of extracellular signals (15). The GPCR-mediated
activation of PKCc and ERK1/2 kinases is part of the negative
regulation of certain GPCRs, such as the MOR and CB1R (9,
13). Thus, NO signaling participates in GPCR desensitization,
although it is also required for the GRK- and b-arrestin-
dependent internalization of these receptors. The agonist-
induced production of NO separates b-arrestin from NOS
binding and it targets the released b-arrestin to clathrin, ini-
tiating internalization of the GRK-phosphorylated GPCR (41).
These are just a few examples of the relevance of redox pro-
cesses and zinc mobilization in GPCR-mediated neuronal
signaling.
The link between the glutamate NMDAR, NO production,
and nitrosative signaling has been well documented. Thus, in
postsynaptic neuron nNOS binds to PDZ binding motifs in
the PSD-95 scaffold protein via its N terminal PDZ domain.
FIG. 4. The RGSZ2 protein is required for NO-mediated
release of endogenous zinc in response to GPCR activa-
tion. The zinc-releasing activity of different GPCR agonists
was analyzed in coronal slices obtained from control mice and
mice with defective RGSZ2 expression. Antisense oligodeox-
ynucleotides for RGSZ2 mRNA effectively reduced the ex-
pression of the protein (11, 14). The agonists indicated were
administered at 10 lM and the fluorescent data were obtained
60 min post-agonist treatment. All details as in Figures 1 and
2. (To see this illustration in color the reader is referred to the
web version of this article at www.liebertpub.com/ars).
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NMDAR activation then leads to calcium permeation and the
formation of intracellular calcium–calmodulin complexes that
activate nNOS to produce NO, as well as producing other
effects. NMDAR signaling is propagated by NO-mediated S-
nitrosylation of the cysteine residues of many proteins, such
as N-ethylmaleimide sensitive factor and stargazing, which
directly regulate the function of the AMPAR, and that of the
NMDAR indirectly (49). The mechanisms underlying GPCR-
induced NO/zinc signaling have principally been analyzed
for the MOR, identifying the fundamental role of HINT1. The
HINT1 protein is a member of the HIT family of proteins that
display conserved sequence identity in a broad range of
FIG. 5. A series of GPCRs associate
with RGSZ2 and HINT1 proteins in
brain synaptosomal membranes. (A)
Antibodies (affinity-purified IgGs) di-
rected against extracellular domains of
the GPCRs of interest. (B) Solubilized
synaptosomes from mouse cerebral
cortex were incubated with the
described biotinylated anti GPCR an-
tibodies. After recovery with strepta-
vidin-sepharose, the GPCR-containing
complexes were processed to remove
the IgG before immunodetection of
the GPCR and associated proteins
(see Materials and Methods). Im-
munodetection of the GPCR and co-
precipitated nNOS, RGSZ2, and
HINT1 proteins: For each GPCR, the
organization of cytosolic third loop
and C terminus is indicated. The
dividing line indicates that RGSZ2 and
HINT1 immunodetection for CB1R
and a2AR was performed in a separate
blot.
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FIG. 6. Physical association
of GPCR cytosolic regions
with RGSZ2 protein. BiFC
analysis: RGSZ2 interaction
with GPCRs. CHO cells were
transiently co-transfected with
cDNAs encoding RGSZ2VC155
and the corresponding
GPCRVN173 (0.8 lg). Fluor-
escent signals were only ob-
tained after the direct
physical association of both
proteins, which allows VC155
and VN173 to correctly as-
semble the active fluorescent
molecule. Fluorescent images
showing positive cells in the
observed field are shown.
SPR analysis: The cytosolic
third loop or N terminal re-
gion of the GPCR under
study was covalently an-
chored to a CM5 chip and
RGSZ2 protein added in the
fluid phase. Binding of
RGSZ2 to the GPCR amino
acid sequence was detected
through the increase in reso-
nance units (RU). BSA was
used as a negative control.
(To see this illustration in
color the reader is referred to
the web version of this article
at www.liebertpub.com/ars).
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organisms including mycoplasma, plants, and humans.
HINT1 exists as a homodimer that specifically binds zinc ions
without affecting its tertiary structure (25, 43), suggesting that
zinc participates in HINT1’s interaction with third party
proteins. Interestingly, HINT1 was initially named as a PKC
inhibitory (PKCi) protein, as it binds to the regulatory domain
of conventional PKC isoforms and stabilizes this kinase in its
inactive form (25, 35). Like the PSD-95, the RGSZ2 protein
contains PDZ binding motifs that recruit nNOS, and these
RGSZ2–nNOS complexes couple to the cytosolic C terminus
of the MOR via the HINT1 protein (1, 14, 18, 43). The inter-
action of HINT1 with RGSZ2 does not require zinc ions, al-
though binding of PKCc to the HINT1 protein is clearly
dependent on this metal ion. The binding of zinc ions to the
PKCc C1 regulatory domain promotes its folding into the
inactive conformation of the kinase (50) that can interact with
the HINT1 protein. Accordingly, zinc-depleted PKCc displays
poor affinity for the HINT1 protein, while this interaction was
strongly enhanced in the presence of zinc ions. This obser-
vation indicates that zinc also participates in this intermolec-
ular interaction probably trough is simultaneous binding to
HINT1 histidines and PKCc zinc finger cysteines.
Thus, a series of concurrent processes position the inactive
PKCc in the MOR environment where its activation can be
tightly regulated to prevent the unwanted spreading of its
effects. In this domain, MOR-activated PLCb provides DAG
to activate the HINT1-bound PKCc. By interacting with the
histidines of the PKC regulatory domain, this DAG lipid
signal releases part of the zinc content and unfolds the kinase
into its active conformation (23, 24, 50). Moreover, by acting
on HINT1 histidines, DAG would also provoke the release of
the zinc ions required to support PKCc-HINT1 inhibitory
association. This action weakens the intermolecular bridging
and disorders the surface of PKCc involved in its binding to
HINT1, favoring the release of the active kinase. Similarly,
MOR-released zinc ions also promote the binding of inactive
Raf-1 to the HINT1 protein, facilitating PKCc-mediated acti-
vation of the Raf-1-ERK1/2 pathway (45). PKC can also be
activated by reactive oxygen species (ROS); however, ROS do
not enhance the activation promoted by cofactors such as
DAG and calcium but rather, they fix the kinase in a persis-
tent, autonomously active form (19, 22). Significantly,
NADPH oxidase/ROS production and the sustained activa-
tion of PKCc triggered by opioids are essential to develop and
maintain NMDAR-mediated tolerance to the analgesic effects
of morphine (8, 44). Thus, the action of PKCc on NADPH
oxidase subunits promotes the production of ROS (3), which
remove the DAG-resistant zinc from the regulatory domain of
PKCc and fix the kinase in its active form (22).
The concept of a biological redox switch, or more specifi-
cally, redox zinc switch, involves motifs in peptides or pro-
teins that utilize the redox chemistry of cysteine thiol groups
to bind and release zinc ions (32, 39). Controlling the
FIG. 7. In vitro association between RGSZ2/PKCc and
HINT1, and ex vivo association between PKCc/Raf1 and
different GPCRs: the effect of zinc ions. (A) The HINT1
protomer was used at 200 nM, whereas GST-RGSZ2 and
GST-PKCc were used at 100 nM. GST alone did not bind to
the HINT1 protein (negative control). The interaction of the
signaling proteins was studied before and after zinc was
removed from the recombinant proteins (TPEN-EDTA buff-
er). After the removal of zinc, the influence of increasing
concentrations of zinc on these interactions was studied.
Glutathione sepharose 4B was added to capture the GST
fusion protein and the associated HINT1 protein. The pro-
teins were then resolved by SDS-PAGE chromatography and
the presence of HINT1 was analyzed in Western blots. (B)
Brain synaptosomes were incubated with zinc chloride for
4 h at 4C. Free zinc was removed by three cycles of centri-
fugation and washing. Next, GPCRs were im-
munoprecipitated, and the associated PKCc and Raf1 were
detected using appropriate antibodies. The study was re-
peated at least twice using different preparations from cor-
tical synaptosomes. Data are expressed as the mean– SEM
with respect to the control (no zinc, arbitrary value of 1).
Equal loading was determined from the GPCR signal. *Sig-
nificant difference with respect to the control group, p< 0.05.
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availability of zinc and the cysteine ligand-based redox reac-
tions is essential to modulate certain transient heterologous
protein-protein interactions (quinary structure) (32). Lipid
second messengers such as DAG, as well as redox action and
zinc ions, dynamically regulate PKC activity by switching the
kinase between its unfolded active and folded inactive state,
the latter binding more readily to the HINT1 protein at the
GPCRs. Both activating agents, lipid second messengers and
ROS, release zinc ions from PKC (22, 50) and within a given
kinase activation cycle, zinc must remain in close proximity to
facilitate the recovery of the kinase for the next cycle (23).
These requirements, coupled with the compartmentalization
of GPCR redox signaling, suggest that the NO-sensitive
source of zinc ions should be incorporated into this regulatory
machinery. As RGSZ2 exerts an inhibitory influence on NO
production, which is lifted upon MOR activation (14, 47), our
results indicate that the regulation of the zinc finger of RGSZ2
by mild oxidation of nNOS/NO could be coupled to PKC,
providing the kinase with the zinc ions necessary for it to
reach its inactive state and bind to the HINT1 protein in the
surroundings of the GPCR (Fig. 9). The release of zinc ions
appears not to compromise other functions of RGSZ2 and
thus, the RGSZ2 redox zinc switch would appear to act as a
redox transducer (32) that releases zinc (‘‘zinc signal’’), which
can in turn modulate the activity of PKCc and Raf-1, among
other targets. By contrast, PKC behaves as a redox sensor,
whereby the ROS-induced release of zinc ions alters its ac-
tivity (kinase activation).
The excess generation of NO and NO-derived reactive ni-
trogen species leads to nitrosative stress and altered cell metal
ion metabolism, both of which have been implicated in the
pathophysiology of neural disorders (17, 37). Typically,
NMDAR overactivation at least partially contributes to neu-
rological diseases such as Alzheimer’s and Parkinson’s dis-
eases, multiple sclerosis, and amyotrophic lateral sclerosis
(27), as well as mood disorders such as schizophrenia and
depression (29, 36). Nonetheless, the link between GPCR
signaling, NO production, and zinc metabolism raises the
possible role of metabotropic receptors in certain neural dis-
orders. The GPCR-associated and nNOS-coupled RGSZ2
protein is implicated in human cognitive ability, while
the genome wide association database links this gene to
Alzheimer’s disease, narcolepsy, and panic disorder (https://
gwas.lifesciencedb.jp/cgi-bin/gwasdb/gwas_gene.cgi?name=
RGS17 accessed on Jul 2, 2012). Moreover, where the RGSZ2
gene resides, locus 6q25, is one of the most relevant loci for
schizophrenia-susceptibility on this chromosome (26). Im-
paired RGSZ2 expression also induces overstimulation of the
nNOS/NO pathway, as well as rapid and durable loss of
GPCR function (14). The HINT1 protein has also been impli-
cated in certain mental disorders, including schizophrenia and
bipolar disorder (2). A disruption in zinc homeostasis is in-
creasingly associated with the pathophysiology of affective
disorders and interestingly, depression has been correlated
with serum hypozincemia. Indeed, zinc exhibits antidepres-
sant-like activity in preclinical animal models. Moreover, the
efficacy of antidepressants that block serotonin reuptake and
normalize serum zinc levels suggests that this effect is medi-
ated by GPCRs (5, 38). Dysfunction of aminergic receptors,
such as 5HT1A and 5HT2A, is typically implicated in depres-
sion. Thus, impaired coupling of these serotonin receptors to
redox signaling (e.g., nNOS regulation and NO-dependent
FIG. 8. NO provides the zinc ions required for PKCc to
associate with GPCRs: the effect of PMA on NO/zinc-
induced PKCc recruitment to GPCRs. (A) Synaptosomal
membranes derived from mouse cerebral cortex were incu-
bated with the NO donor SNAP (30lM, 100lM, and
300 lM) in the presence or absence of the heavy-metal ion
chelator TPEN (100 lM), and the effects on the association of
PKCc with the different GPCRs were evaluated. (B) In-
cubation of synaptosomal membranes with phorbol-12-
myristate-13-acetate (PMA, 5lM) diminished the association
of GPCRs with PKCc. The GPCRs served as a loading con-
trol. (C) The association of zinc-free PKCc and HINT1 was
promoted by the presence of 1 lM zinc chloride. After re-
moval of the free zinc ions, the effect of PMA on the HINT1-
PKCc association was evaluated, as was the activity of the
kinase.
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release of zinc ions) may diminish their signaling capacity. In
such cases, the strength of the zinc signals produced by these
GPCRs can be improved by increasing agonist input, as occurs
when serotonin reuptake is inhibited by antidepressants. Given
the implication of zinc homeostasis in brain disorders, several
therapies based on metal ion chelation, redistribution and
supplementation are currently in development (16).
In summary, we found that a range of neuronal GPCRs that
respond to endogenous ligands of diverse chemical nature all
physically couple with the RGSZ2-nNOS signaling complex.
Activation of these receptors increases NO production and
releases zinc ions from redox zinc switches, such as the RGSZ2
protein. These findings demonstrate that GPCR signaling
depends on redox processes and zinc mobilization for suc-
cessful integration into neuronal metabolism.
Materials and Methods
Zinc microfluorescence imaging in CD1 mouse
striatal slices
To image intracellular Zn2+ , brain slices (200lm thick) were
preloaded for 1 h with 50lM of cell-permeable Newport Green
DCF diacetate (N7991, Invitrogen), 0.1% pluronic acid
(P3000MP, Invitrogen), and 0.5% dimethyl sulfoxide, as de-
scribed previously (45). Saline, agonists, and antagonists
were added to the wells, and the contribution of NO to zinc
signals was determined using the NOS inhibitor NG-nitro-L-
arginine (L-NNA). Images were obtained by confocal micros-
copy on a Leica DMIII 6000 CS confocal fluorescence microscope
equipped with a TCS SP5 scanning laser (excitation, 488 nm;
emission, 498–520 nm) and using a 10·0.4 HC PL APO objec-
tive. See also Supplementary Materials and Methods (Supple-
mentary data are available online at www.liebertonline/ars).
In vitro determination of zinc release from rRGSZ2
Free zinc ions were detected as described previously (45).
The N-terminal (Nt) region of RGSZ2 was obtained as a GST
fusion protein and this RGSZ2 Nt protein was incubated for
30 min at RT with 100 lM ZnCl2. Free zinc was removed by
extensive washing and centrifugation in an Amicon Ultra-4
centrifugal filter device (UCF8 01024), followed by buffer
exchange in PD-10 gel chromatography columns (GE
FIG. 9. Scheme describing the regulation of NO produc-
tion by GPCRs and the release of zinc ions from the
RGSZ2 zinc finger. (A) The C terminus or third internal loop
of the GPCR binds directly to the RGSZ2–nNOS signaling
complex, which may also associate with the GPCR indirectly
via the HINT1 protein. (B) Agonist binding activates GaGTP
subunits [1], some of which bind to the RGS domain in the
RGSZ2 protein [2]. This action releases the inhibition of
nNOS activity by RGSZ2 [3], (C) resulting in the production
of NO [2], which in turn releases zinc ions from the cysteine
residues of the RGSZ2 zinc finger [2]. PKC is a zinc-binding
protein (40), and these ions stabilize the inactive folded form
of the kinase that binds to the GPCR-coupled HINT1 protein.
Zinc binding to the PKCc regulatory domain also increases
its affinity for cofactors such as DAG [3]. DAG produced by
PLCb releases PKCc from its inhibitory association with the
HINT1 protein, also releasing part of the PKCc-associated
zinc and thereby promoting the unfolding of the kinase to an
active conformation (24). The ROS produced by NADPH
oxidase releases the DAG-resistant zinc from the PKCc CDR
and fixes the kinase in a persistent active form (22, 50). After
DAG is released, PKC activity diminishes, and it requires
zinc to again bind to DAG (6, 7). Thus, a new PKC recruit-
ment/activation cycle can start at the GPCR.
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Healthcare 17-0851-91). GST-RGSZ2 Nt was concentrated
(20 lM) and then exposed at the intervals indicated to 100lM
of the NO donors SNAP and NOR-3, or to 2.5 mM hydrogen
peroxide (all in HEPES buffer; 25 mM, pH 7.8). Complexing
was initiated by adding the zinc chelator Zincon (40 lM;
Sigma #96440) and the optical density was read at 600 nm.
Another set of assays was performed by adding TSQ to the
protein samples at a final concentration of 10lM. The RGSZ2
Nt-containing samples were excited at 334 nm and fluores-
cence emission was recorded at 465 nm in a spectrofluorime-
ter. A standard zinc solution (Sigma 39059) was used to
calibrate the assay systems.
Preparation and solubilization of the
synaptoneurosome-enriched fraction: GPCR
immunoprecipitation and co-precipitation
of associated proteins
All procedures involving mice were performed in strict
accordance with the guidelines of the European Community
for the Care and Use of Laboratory Animals (Council Direc-
tive 86/609/EEC), and Spanish Law regulating animal re-
search (RD 1201/2005). The experimental protocols were
reviewed and approved by the Committee for Animal Ex-
perimentation at the CSIC.
For the immunoprecipitation studies, the cerebral cortex
from 8 CD1 mice (Charles River, Spain) were pooled, and the
assays were repeated at least twice with samples obtained
from different mice. The methods used to prepare the PAG
synaptosomal fraction have been described previously (46).
The affinity-purified IgGs against the extracellular domains of
GPCRs were labeled with biotin (Pierce 21217 and 21339), and
immunoprecipitated from solubilized membranes as de-
scribed (12, 42). The immunoprecipitated proteins were re-
solved by SDS/polyacrylamide gel electrophoresis (PAGE) in
10 cm· 10 cm · 1.5 mm gel slabs (7%–14% total acrylamide
concentration, 2.6% bisacrylamide cross-linker concentra-
tion), and the separated proteins were then transferred to
0.2 lm PVDF membranes and probed with the selected anti-
bodies in DecaProbe chambers (PR 150, Hoefer-GE, Barcelo-
na, Spain). The primary antibodies were detected using the
corresponding secondary antibodies and visualized by ECL
(RPN2132, Amersham Biosciences).
Bimolecular fluorescence complementation analysis
The pPD49.83 plasmid was used to generate two cloning
vectors for BiFC analysis (44). The constructs containing the
N-terminal fragment of Venus truncated at residue 173
(VN173) or the C-terminal fragment of Venus starting at res-
idue 155 (VC155) were a gift from Dr Chang-Deng Hu at
Purdue University (USA). Chinese hamster ovary (CHO) cells
were transfected using Lipofectamine 2000 (Invitrogen) and
incubated for 24 h prior to testing for transgenic expression.
Samples were visualized on glass bottom plates (MatTek Co,
MA) using a Leica DMIII 6000 CS confocal fluorescence mi-
croscope equipped with a TCS SP5 scanning laser.
Surface plasmon resonance analysis
Interactions were determined using a BIACORE X (GE)
as described previously (43). The GPCRs (50lg/mL) were
coupled to a CM5 sensor chip (GE, BR-1000-14) by amine
coupling, and sensorgrams were collected at 25C at a flow
rate of 5lL/min after passing RGSZ2 (75 lL) over the sen-
sor surface. Increasing analyte concentrations were studied
and the results were plotted using the BIAevaluation soft-
ware (v 4.1).
In vitro interaction between RGSZ2/PKCg and HINT1
proteins: The effects of zinc ions and PMA
The interaction of recombinant HINT1 (200 nM) with either
GST-RGSZ2 (100 nM) or GST-PKCc (100 nM; Abnova #P4759)
was studied. Zinc was first removed from the recombinant
proteins by incubating them for 60 min at room temperature
(RT) in a buffer containing 10 mM HEPES (pH 7.5), 150 mM
NaCl, 5 mM EDTA, 200lM DTT, and 1 mM N,N,N¢,N¢-tet-
rakis(2-pyridylmethyl) ethylenediamine (TPEN) (48). The
samples were diluted in 10 mM HEPES (pH 7.5), 150 mM
NaCl, and concentrated in centrifugal filter devices (10 kDa
nominal molecular weight limit: Amicon Microcon YM-10
#42407, Millipore). After zinc removal with TPEN, the influ-
ence of added zinc on the association of the recombinant
proteins was evaluated by incubating them either alone
(negative control) or together with the GST tagged protein in
400 lL of a buffer containing 10 mM HEPES (pH 7.4), 150 mM
NaCl, and 0.05% Tween20. Recombinant HINT1 was incu-
bated for 30 min with rotation at RT with GST-RGSZ2 or GST-
PKCc in the presence of increasing amounts of zinc chloride:
1 pM, 1 nM, and 1 lM (Puratronic, Alfa Aesar 231-592-0).
Subsequently, 40 lL glutathione Sepharose 4B (GE#17 0756
01) was added to the protein mixture, which was then re-
covered by centrifugation, washed three times, solubilized in
2X Laemmli buffer, and the presence of HINT1 was analyzed
in Western blots. In another set of assays, endogenous zinc
was first removed from the HINT1 and GST-PKCc proteins,
and they were then incubated in the presence of 1lM zinc
chloride for 30 min at RT before the free zinc was removed
using 10 kDa nominal molecular weight limit centrifugal filter
devices (Amicon Microcon YM-10 #42407, Millipore). Parallel
samples were used to evaluate the disrupting effect of PMA
(Calbiochem #524400) on the PKCc/HINT1 association, as
well as on the resulting enzymatic activity of this PKCc. The
latter was determined using the Pep Tag protein kinase C
assay (Promega, Madison, WI). Samples containing the
HINT1/PKCc complexes that had been exposed to PMA were
incubated for 30 min at 30C with the specific substrate in the
presence of an activating solution. The reaction was stopped
at 95C for 10 min and the PKCc-induced phosphorylation of
the peptide substrate was determined.
In vitro effect of zinc ions on the recruitment
of signaling proteins to GPCRs: Influence of zinc
chelation and NO generators
The effect of increasing concentrations of zinc on the asso-
ciation of PKCc and Raf-1 with various GPCRs was studied in
cortical synaptosomal membranes. Membranes were incu-
bated with zinc chloride (Puratronic, Alfa Aesar 231-592-0) for
4 h at 4C before the GPCRs were immunoprecipitated. Sub-
sequently, free zinc ions were removed by centrifugation and
extensive washing. The synaptosomal membranes were then
solubilized in Nonidet P-40 buffer as described previously.
The solubilized membranes were incubated overnight at 4C
with approximately 3 lg of a biotin (Pierce #21217 and 21339)
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conjugated primary antibody (affinity-purified IgGs) raised
against extracellular sequences in 5HT1AR, 5HT2AR, CB1R,
and D2R. The GPCR-associated proteins were then separated
by SDS-PAGE and analyzed by Western blotting. The sam-
ples were incubated overnight at 4C with the NO generator
SNAP (Tocris Bioscience #0598) and the anti-GPCRs IgGs, and
the procedure was continued as described above. The heavy
metal ion chelator TPEN (Fluka WA16827) was added to the
solubilized samples together with SNAP.
Statistical analyses
ANOVA, followed by the Student-Newman-Keuls test
(SigmaStat, SPSS Science Software, Erkrath, Germany) was
used for the statistical analyses. The significance was defined
as p< 0.05.
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Abbreviations Used
5HT1AR¼ serotonin receptor 5HT1A
5HT2AR¼ serotonin receptor 5HT2A
a2AR¼ adrenergic receptor a2A
BiFC¼ bimolecular fluorescence complementation
CB1R¼ cannabinoid receptor 1
CRD¼ cysteine-rich domain
D1R¼dopamine receptor 1
D2R¼dopamine receptor 2
DAG¼diacylglycerol
DOR¼delta opioid receptor
GPCR¼G protein-coupled receptor
HINT1¼histidine triad nucleotide-binding protein 1
L-NNA¼NG-nitro-L-arginine
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Abbreviations Used (Cont.)
M2R¼ acetylcholine muscarinic receptor M2
M4R¼ acetylcholine muscarinic receptor M4
mGlu2R¼ glutamate metabotropic receptor 2
mGlu5R¼ glutamate metabotropic receptor 5
MOR¼mu opioid receptor
NMDAR¼N-methyl-D-aspartate receptor
nNOS¼neural nitric oxide synthase
NO¼nitric oxide
NOR-3¼ (–)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-
3-hexeneamide
PDZ¼protein motif [post synaptic density protein
(PSD95), Drosophila disc large tumor suppressor
(DlgA), and zona occludens-1 protein (zo-1)]
PKC¼protein kinase C
PLC¼phospholipase C
PMA¼phorbol 12-myristate 13-acetate
RGSZ2¼ regulator of G protein signaling Z2
ROS¼ reactive oxygen species
SNAP¼ (S)-nitroso-N-acetylpenicillamine
TPEN¼N,N,N¢,N¢-tetrakis(2-pyridylmethyl)
ethylenediamine
RGSZ2-MEDIATED REDOX SIGNALING OF GPCRS 15
